Who founded Remedy Plan?

Remedy Plan was founded by Gregory Plan Crimmins.

Who are Remedy Plan's investors?

Remedy Plan's investors include 20/20 HealthCare Partners LLC, Schooner Capital.

How much funding has Remedy Plan raised?

Remedy Plan has disclosed $25.8M raised across 3 rounds.

Where is Remedy Plan headquartered?

Remedy Plan is headquartered in Rockville, US.

Remedy Plan

Rockville, US · Delaware corporation · 2 known investors

Remedy Plan is a biopharmaceutical company developing drugs that target NAMPT, an essential enzyme dysregulated in more than 20 diseases including cancer. Its lead clinical candidate, RPT1G, is a hyperbolic inhibitor designed to reduce NAMPT activity while avoiding the toxicity that has limited earlier attempts.

Biotech Healthtech

Founders & leadership

Gregory Plan CrimminsFounder

Investors · 2

20/20 HealthCare Partners LLCAuburndalevia Hillel Bachrach · inferred

Schooner CapitalBoston

Reported raises · per SEC filings

Form D private placements

$25.8M disclosed across 3 rounds · 2018–2023

▶$19.1MraisedAug 2023 · 22 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Owen HughesDirector
Frank McCormickDirector
Gregory CrimminsExecutive Officer, Director
Alexandra ManickDirector

Offering amount: $19.6M
Amount sold: $19.1M
First sale: Jul 2023
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$5.2MraisedDec 2019 · 10 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Frank McCormickDirector
Alexandra ManickDirector
Gregory CrimminsExecutive Officer, Director

Offering amount: $7.2M
Amount sold: $5.2M
First sale: Nov 2019
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$1.5MraisedNov 2018 · 6 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Gregory Plan CrimminsExecutive Officer, Director

Offering amount: $1.5M
Amount sold: $1.5M
Minimum investment: $100K
First sale: Nov 2018
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Remedy Meds5 shared keywordsRemedy Meds offers personalized medical weight loss treatment using compounded GLP-1 medications (semaglutide and tirzepatide) paired with clinician-led care and support delivered directly to patients. The service targets individuals seeking prescription-based weight loss solutions with ongoing medical supervision and community support.

Companies competing with Remedy Plan for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Remedy Plan do?: Remedy Plan is a biopharmaceutical company developing drugs that target NAMPT, an essential enzyme dysregulated in more than 20 diseases including cancer. Its lead clinical candidate, RPT1G, is a hyperbolic inhibitor designed to reduce NAMPT activity while avoiding the toxicity that has limited earlier attempts.
Who founded Remedy Plan?: Remedy Plan was founded by Gregory Plan Crimmins.
Who are Remedy Plan's investors?: Remedy Plan's investors include 20/20 HealthCare Partners LLC, Schooner Capital.
How much funding has Remedy Plan raised?: Remedy Plan has disclosed $25.8M raised across 3 rounds.
Where is Remedy Plan headquartered?: Remedy Plan is headquartered in Rockville, US.